Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Preferred Stock Liabilities (2017 - 2018)

Historic Preferred Stock Liabilities for Altimmune (ALT) over the last 2 years, with Q2 2018 value amounting to $510083.0.

  • Altimmune's Preferred Stock Liabilities changed N/A to $510083.0 in Q2 2018 from the same period last year, while for Jun 2018 it was $510083.0, marking a year-over-year change of. This contributed to the annual value of $9.3 million for FY2017, which is N/A changed from last year.
  • Per Altimmune's latest filing, its Preferred Stock Liabilities stood at $510083.0 for Q2 2018.
  • Altimmune's 5-year Preferred Stock Liabilities high stood at $9.3 million for Q4 2017, and its period low was $510083.0 during Q2 2018.